(Q39289770)

10 September 2017

Ketanserin in the treatment of traumatic vasospastic disease (English)

1 reference

10 September 2017

Larsen VH

1

1 reference

10 September 2017

Fabricius J

series ordinal

2

1 reference

10 September 2017

Nielsen G

series ordinal

3

1 reference

10 September 2017

Hansen KS

series ordinal

4

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 September 1986

1 reference

10 September 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

The BMJ

1 reference

10 September 2017

293

1 reference

10 September 2017

6548

1 reference

10 September 2017

650-652

1 reference

Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1341509

Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1341509

The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1341509

Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1341509

17 June 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/3092968

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

10 September 2017

PubMed publication ID

3092968

1 reference